IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression

Mucosal Immunology

Volumn 3, Issue 3, 2010, Pages 301-311

  Durrant, D M ^a   Metzger, D W ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR T BET;

ALLERGIC PNEUMONITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; INFLAMMATORY CELL; KNOCKOUT MOUSE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; TH1 CELL; TH17 CELL;

EID: 77951490936     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.9     Document Type: Article

References (72)

1. Wills-Karp, M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281 ( 1999 ). (Pubitemid 29241125)
2. Nakajima, H. & Takatsu, K. Role of cytokines in allergic airway inflammation. Int. Arch. Allergy Immunol. 142, 265-273 ( 2007 ). (Pubitemid 46425806)
3. Herrick, C. A. & Bottomly, K. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3, 405-412 ( 2003 ). (Pubitemid 37323200)
4. Jatakanon, A. et al. Neutrophilic inflammation in severe persistent asthma. Am. J. Respir. Crit. Care Med. 160, 1532-1539 ( 1999 ).
5. Louis, R. et al. The relationship between airways inflammation and asthma severity. Am. J. Respir. Crit. Care Med. 161, 9-16 ( 2000 ). (Pubitemid 30055896)
6. Laan, M., Palmberg, L., Larsson, K. & Linden, A. Free, soluble interleukin- 17 protein during severe inflammation in human airways. Eur. Respir. J. 19, 534-537 ( 2002 ). (Pubitemid 34256972)
7. Molet, S. et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108, 430-438 ( 2001 ). (Pubitemid 32881066)
8. Chakir, J. et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111, 1293-1298 ( 2003 ). (Pubitemid 36683685)
9. Hellings, P. W. et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28, 42-50 ( 2003 ).
10. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17- deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 ( 2002 ). (Pubitemid 35279557)
11. Schnyder-Candrian, S. et al. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203, 2715-2725 ( 2006 ). (Pubitemid 44833347)
12. He, R., Oyoshi, M. K., Jin, H. & Geha, R. S. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl Acad. Sci. USA 104, 15817-15822 ( 2007 ). (Pubitemid 350035382)
13. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. & Murphy, K. M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688 ( 2006 ). (Pubitemid 43867371)
14. Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 ( 2003 ).
15. Murphy, C. A. et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951 - 1957 ( 2003 ).
16. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 ( 2007 ). (Pubitemid 46232884)
17. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 ( 2006 ). (Pubitemid 43214587)
18. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 ( 2006 ).
19. Mangan, P. R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234 ( 2006 ).
20. Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 ( 2005 ).
21. Ivanov, II et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133 ( 2006 ).
22. Yang, X. O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28, 29-39 ( 2008 ).
23. Acosta-Rodriguez, E. V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639-646 ( 2007 ).
24. Annunziato, F. et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204, 1849 - 1861 ( 2007 ). (Pubitemid 47240944)
25. Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 ( 2005 ).
26. Stumhofer, J. S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945 ( 2006 ).
27. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 ( 2005 ). (Pubitemid 41541791)
28. Durrant, D. M., Gaffen, S. L., Riesenfeld, E. P., Irvin, C. G. & Metzger, D. W. Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J. Immunol. 183, 5293-5300 ( 2009 ).
29. Fujiwara, M. et al. T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J. Allergy Clin. Immunol. 119, 662-670 ( 2007 ). (Pubitemid 46320593)
30. Coyle, A. J. et al. Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 156, 2680-2685 ( 1996 ).
31. McDyer, J. F., Wu, C. Y. & Seder, R. A. The regulation of IL-12: its role in infectious, autoimmune, and allergic diseases. J. Allergy Clin. Immunol. 102, 11-15 ( 1998 ). (Pubitemid 28345777)
32. Smits, H. H. et al. IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. Eur. J. Immunol. 31, 1055-1065 ( 2001 ).
33. Kips, J. C. et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153, 535-539 ( 1996 ). (Pubitemid 26051325)
34. Sur, S. et al. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157, 4173-4180 ( 1996 ). (Pubitemid 126449332)
35. Gavett, S. H. et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182, 1527-1536 ( 1995 ).
36. Iwamoto, I., Kumano, K., Kasai, M., Kurasawa, K. & Nakao, A. Interleukin- 12 prevents antigen-induced eosinophil recruitment into mouse airways. Am. J. Respir. Crit. Care Med. 154, 1257-1260 ( 1996 ). (Pubitemid 26391165)
37. Schwarze, J. et al. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J. Allergy Clin. Immunol. 102, 86-93 ( 1998 ). (Pubitemid 28345788)
38. Matsuse, H. et al. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Int. Immunopharmacol. 3, 457-468 ( 2003 ). (Pubitemid 36419507)
39. Bruselle, G. G. et al. Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12. Am. J. Respir. Cell Mol. Biol. 17, 767-771 ( 1997 ).
40. Daftarian, P. M., Kumar, A., Kryworuchko, M. & Diaz-Mitoma, F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J. Immunol. 157, 12-20 ( 1996 ). (Pubitemid 26190527)
41. Meyaard, L., Hovenkamp, E., Otto, S. A. & Miedema, F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156, 2776-2782 ( 1996 ). (Pubitemid 126660624)
42. Jeannin, P., Delneste, Y., Seveso, M., Life, P. & Bonnefoy, J. Y. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J. Immunol. 156, 3159-3165 ( 1996 ). (Pubitemid 26123528)
43. Gu, Y. et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. 38, 1807 - 1813 ( 2008 ).
44. Djuretic, I. M. et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8, 145-153 ( 2007 ).
45. Paul, W. E. & Seder, R. A. Lymphocyte responses and cytokines. Cell 76, 241-251 ( 1994 ). (Pubitemid 24046687)
46. Mathur, A. N. et al. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 108, 1595-1601 ( 2006 ).
47. Wagers, S., Lundblad, L. K., Ekman, M., Irvin, C. G. & Bates, J. H. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J. Appl. Physiol. 96, 2019-2027 ( 2004 ). (Pubitemid 38661478)
48. Pearce, E. L. et al. Control of effector CD8+ T cell function by the transcription factor eomesodermin. Science 302, 1041-1043 ( 2003 ). (Pubitemid 37386196)
49. Koch, M. et al. Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 35, 211-219 ( 2006 ). (Pubitemid 44175321)
50. Sundstedt, A., O ' Neill, E. J., Nicolson, K. S. & Wraith, D. C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170, 1240-1248 ( 2003 ). (Pubitemid 36139489)
51. Robinson, D. S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304 ( 1992 ).
52. Manetti, R. et al. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J. Exp. Med. 179, 1273-1283 ( 1994 ). (Pubitemid 24091786)
53. Schulz, E. G., Mariani, L., Radbruch, A. & Hofer, T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. Immunity 30, 673-683 ( 2009 ).
54. Portielje, J. E. et al. Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant. Cancer Immunol. Immunother. 54, 37-43 ( 2005 ).
55. Lee, Y. K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92-107 ( 2009 ).
56. Windhagen, A., Anderson, D. E., Carrizosa, A., Williams, R. E. & Hafler, D. A. IL-12 induces human T cells secreting IL-10 with IFN-gamma. J. Immunol. 157, 1127-1131 ( 1996 ). (Pubitemid 126449626)
57. Jankovic, D. et al. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10( - / - ) setting. Immunity 16, 429-439 ( 2002 ). (Pubitemid 34260920)
58. Saraiva, M. et al. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31, 209-219 ( 2009 ).
59. Henry, E. et al. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J. Immunol. 181, 7230-7242 ( 2008 ).
60. Campbell, J. D. et al. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J. Exp. Med. 206, 1535-1547 ( 2009 ).
61. Ling, E. M. et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363, 608-615 ( 2004 ).
62. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 ( 2003 ). (Pubitemid 36222930)
63. Mullen, A. C. et al. Role of T-bet in commitment of TH1 cells before IL-12- dependent selection. Science 292, 1907 - 1910 ( 2001 ).
64. Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 ( 2000 ).
65. Szabo, S. J., Sullivan, B. M., Peng, S. L. & Glimcher, L. H. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21, 713-758 ( 2003 ). (Pubitemid 37174546)
66. Finotto, S. et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295, 336-338 ( 2002 ). (Pubitemid 34074365)
67. Raby, B. A. et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 173, 64-70 ( 2006 ).
68. Munthe-Kaas, M. C. et al. T cell-specific T-box transcription factor haplotype is associated with allergic asthma in children. J. Allergy Clin. Immunol. 121, 51-56 ( 2008 ).
69. Alouani, S., Juillard, P. & Chvatchko, Y. Murine model of allergic lung inflammation. Methods Mol. Biol. 138, 285-293 ( 2000 ).
70. Takeda, K., Haczku, A., Lee, J. J., Irvin, C. G. & Gelfand, E. W. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L394-L402 ( 2001 ). (Pubitemid 32756051)
71. Doherty, T. A., Soroosh, P., Broide, D. H. & Croft, M. CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L229-L235 ( 2009 ).
72. Morishima, N., Mizoguchi, I., Takeda, K., Mizuguchi, J. & Yoshimoto, T. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem. Biophys. Res. Commun. 386, 105-110 ( 2009 ).